$VICP

Vicapsys Life Sciences, Inc.

1
0
0

No SEC Form 4 filings for $VICP in the last 30 days.

See all $VICP insider activity →
Med

Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist, Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal

Vicapsys Life Sciences (VICP) completed a reverse merger with Stateline Distributors, a Puerto Rico-based pharmaceutical wholesaler, and acquired NitroMist, a nitroglycerin product, for a $2.0 million convertible note. The company plans to acquire a 120,000 sq ft manufacturing facility in Puerto Rico to produce NitroMist and other products, aiming to serve federal and tribal markets.

VICP sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning VICP (Vicapsys Life Sciences, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

What's driving VICP

AlphAI scores every news story that mentions VICP with an AI model for sentiment and relevance, and aggregates insider trades from Vicapsys Life Sciences, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VICP

Score

Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist, Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal

Vicapsys Life Sciences (VICP) completed a reverse merger with Stateline Distributors, a Puerto Rico-based pharmaceutical wholesaler, and acquired NitroMist, a nitroglycerin product, for a $2.0 million convertible note. The company plans to acquire a 120,000 sq ft manufacturing facility in Puerto Rico to produce NitroMist and other products, aiming to serve federal and tribal markets.

Related tickers